SCHEMBL7964081

SCHEMBL7964081

CCOc1cc(C=C(C#N)S(=O)(=O)c2ccccn2)ccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 11/20 0.62
MEN1 O00255 10/20 0.62
MAPT P10636 4/20 0.62
GAA P10253 3/20 0.62
MAPK1 P28482 2/20 0.62
PKM P14618 4/20 0.59
POLB P06746 3/20 0.59
LMNA P02545 2/20 0.50
EGFR P00533 2/20 0.49
IGF1R P08069 1/20 0.49
IGF2R P11717 1/20 0.49
ALDH1A1 P00352 6/20 0.48
KDM4E B2RXH2 3/20 0.48
HPGD P15428 2/20 0.48
ALPG P10696 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
ALOX15 P16050 1/20 0.48
ALOX12 P18054 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7964079 1.00 KMT2A (0.62) KMT2AMEN1MAPTGAAMAPK1
SCHEMBL7964108 1.00 KMT2A (0.62) KMT2AMEN1MAPTGAAMAPK1
SCHEMBL7954237 0.85 ALDH1A1 (0.68) KMT2AMEN1MAPTGAAMAPK1
SCHEMBL7954239 0.85 ALDH1A1 (0.68) KMT2AMEN1MAPTGAAMAPK1
SCHEMBL7954244 0.85 ALDH1A1 (0.68) KMT2AMEN1MAPTGAAMAPK1
SCHEMBL7963978 0.84 KMT2A (0.68) KMT2AMEN1MAPTGAAMAPK1
SCHEMBL7963974 0.84 KMT2A (0.68) KMT2AMEN1MAPTGAAMAPK1
SCHEMBL7963979 0.84 KMT2A (0.68) KMT2AMEN1MAPTGAAMAPK1
SCHEMBL7962829 0.81 KMT2A (0.61) KMT2AMEN1MAPTGAAMAPK1
SCHEMBL7962827 0.81 KMT2A (0.61) KMT2AMEN1MAPTGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO disclosed